Created at Source Raw Value Validated value
Oct. 21, 2021, 10 a.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Bayesian adaptive randomisation and analysis methodology will accelerate the acquisition of evidence about the effectiveness and safety of proposed new treatments ensure rapid implementation of new treatments.Study treatments or interventions will be added to the trial as a protocol treatment appendix after identification by study investigators and then recommendation by the BEAT COVID-19 Candidate Intervention Expert Committee based on safety; biological plausibility and/or efficacy data. Treatments currently include Ciclesonide. The Ciclesonide domain includes inhaled ciclesonide 320mcg daily for 14 days compared to placebo. Adherence to the intervention will be monitored via a daily participant diary for 28 days post randomisation and follow up calls from the study team.The treatment or intervention will commence once all necessary approvals are obtained.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 282, "treatment_name": "Ciclesonide", "treatment_type": "Corticosteroids", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]

Oct. 26, 2020, 8:29 a.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Bayesian adaptive randomisation and analysis methodology will accelerate the acquisition of evidence about the effectiveness and safety of proposed new treatments ensure rapid implementation of new treatments.Study treatments or interventions will be added to the trial as a protocol treatment appendix after identification by study investigators and then recommendation by the BEAT COVID-19 Candidate Intervention Expert Committee based on safety; biological plausibility and/or efficacy data. No treatments have been identified for inclusion at this date.The treatment or intervention will commence once all necessary approvals are obtained.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]